-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EWPC7IRor1TsSnXt2xWCcbmLjaEtE9d7KrJ3lfFuu6XR5Xrj+vHQcpTYevMCsQKX yBlHN8WOQWcslbkClwBzBw== 0001285612-08-000002.txt : 20080814 0001285612-08-000002.hdr.sgml : 20080814 20080814210747 ACCESSION NUMBER: 0001285612-08-000002 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080630 FILED AS OF DATE: 20080814 DATE AS OF CHANGE: 20080814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC CENTRAL INDEX KEY: 0001016504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133035216 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 201 ROUTE 22 CITY: HILLSIDE STATE: NJ ZIP: 07205 BUSINESS PHONE: 9739260816 MAIL ADDRESS: STREET 1: 201 ROUTE 22 CITY: HILLSIDE STATE: NJ ZIP: 07205 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC DATE OF NAME CHANGE: 20020912 FORMER COMPANY: FORMER CONFORMED NAME: CHEM INTERNATIONAL INC DATE OF NAME CHANGE: 19960716 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAY ROBERT CENTRAL INDEX KEY: 0001285612 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31668 FILM NUMBER: 081021136 MAIL ADDRESS: STREET 1: 225 LONG AVE CITY: HILLSIDE STATE: NJ ZIP: 07205 5 1 inb5_robertkayex.xml X0303 5 2008-06-30 0 0 1 0001016504 INTEGRATED BIOPHARMA INC INBP 0001285612 KAY ROBERT 225 LONG AVE HILLSIDE NJ 07205 1 0 0 0 Restricted Stock Unit 2007-02-07 4 A 0 34000 0 A 1030962 D Common Stock 2008-08-12 4 C 0 200000 .85 A 1030962 D Stock Options 6.80 2007-02-07 4 A 0 16000 0 A 2007-12-20 Common Stock 16000 205333 D Stock Options .85 2008-08-12 4 C 0 200000 0 D 2003-02-04 2013-02-04 Common Stock 200000 205333 D On February 7, 2007, the Reporting Person was granted 34,000 Restricted Stock Units as compensation for serving as a director of the Issuer. Each Restricted Stock Unit consists of a right to the issuance of one share of common stock, par value $.002 ("Common Stock"). The Restricted Stock Units are subject to a three-year vesting period. Represents the amount of securities beneficially owned by the Reporting Person as of the date hereof. On August 5, 2008, the Reporting Person exercised 200,000 options to purchase common stock of the Issuer. The options were originally granted to the Reporting Person for his service as a director of the Issuer. On February 7, 2007, the Reporting Person was granted a stock option to purchase 16,000 shares of Common Stock at an exercise price of $6.80 per share as compensation for serving as a director of the Issuer. These stock options are subject to a three-year vesting period, with an initial annual vesting date of December 20, 2007. /s/ ROBERT KAY 2008-08-14 -----END PRIVACY-ENHANCED MESSAGE-----